Chinese Ointment Company Falsified Lab Results, FDA Says

September 29, 2017

A Chinese maker of pain-relief balms and ointments falsified results of tests on its products and deflected FDA inspectors seeking to examine its laboratory, the FDA said in a warning letter.

The agency in August blocked imports from the company, Shandong Vianor Biotech.

The warning letter, based on a May inspection, said that the company’s lab analysis of an unidentified product determined it was subpotent, but a certificate supporting its export to the U.S. declared it to be within specifications.

Shandong Vianor’s products include Tiger Balm and Ultra Strength Pain Relief Balm for muscle aches.

View today's stories